Darius Tahir - KFF Health News

Even as the COVID-19 pandemic wanes, litigation — whether about vaccines, masks, or a range of other public health policies made during the pandemic — isn’t about to end.

Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

The billionaire entrepreneur, Dallas Mavericks owner and "Shark Tank" star is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.

For contact tracers of sexually transmitted infections, telephones and text messages have become ineffective. Dating apps increasingly are their best bet for informing people of their exposure risks.

A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?

Veterans Affairs’ electronic health records aren’t friendly to blind- and low-vision users, whether they’re patients or employees. It’s a microcosm of America’s health care system.

Medical records can contain seemingly objective descriptions that are actually full of coded language and subtext. How does that affect care?

Russia’s attacks on Ukraine are making it harder for the health care system to secure important supplies, including gases used in imaging and by dentists.

Health data can be shockingly available. A group of nonprofits and corporations is proposing to patch up the holes in health apps, but many of the biggest companies didn’t participate in the proposal’s creation.